Word

Status

Pending

Status Code

732

Status Date

Tuesday, March 12, 2024

Serial Number

97306624

Mark Type

2000

Filing Date

Thursday, March 10, 2022

Published for Opposition

Tuesday, July 19, 2022

Trademark Owner History

Purdue Pharma L.P. - Owner At Publication

Classifications

5 Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists

The mark consists of five small squares and three horizontal lines that transition from solid to decreasing shading.

Trademark Events

Mar 13, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 12, 2024

Sou Extension 3 Granted

Mar 12, 2024

Sou Extension 3 Filed

Mar 12, 2024

Sou Teas Extension Received

Jul 22, 2023

Notice Of Approval Of Extension Request E-Mailed

Jul 20, 2023

Sou Extension 2 Granted

Jul 20, 2023

Sou Extension 2 Filed

Jul 20, 2023

Sou Teas Extension Received

Mar 7, 2023

Notice Of Approval Of Extension Request E-Mailed

Mar 3, 2023

Sou Extension 1 Granted

Mar 3, 2023

Sou Extension 1 Filed

Mar 3, 2023

Sou Teas Extension Received

Sep 13, 2022

Noa E-Mailed - Sou Required From Applicant

Jul 19, 2022

Official Gazette Publication Confirmation E-Mailed

Jul 19, 2022

Published For Opposition

Jun 29, 2022

Notification Of Notice Of Publication E-Mailed

Jun 14, 2022

Approved For Pub - Principal Register

Jun 7, 2022

Assigned To Examiner

Mar 17, 2022

Notice Of Design Search Code E-Mailed

Mar 16, 2022

New Application Office Supplied Data Entered

Mar 14, 2022

New Application Entered